老年跌倒风险药物减停的实施挑战与概念框架:DeFRID试验及全球证据
该叙述性综述结合系统范围要素,综合全球RCT证据与DeFRID试验过程数据,识别减停跌倒风险药物(FRIDs)在伦理、操作、方法学及情境层面的四类挑战,并提出多层次策略以促进可扩展实施。
要点
- 减停FRIDs面临伦理临床、招募留存、跌倒结局判定及印度LMIC情境四类挑战。
- 全球RCT存在低临床依从性、短随访、排除衰弱或认知受损老人及资源密集等问题。
- 需整合培训、共享决策、情境化指南与利益相关者参与的多层次策略。
核心结论
- 老年减停FRIDs受伦理、操作、方法学及医患挑战阻碍,需多层次策略促进可扩展实施。
研究设计与样本
- DeFRID为正在进行的多中心RCT,评估基于ARMOR的减停干预与常规照护,对象为≥60岁且处方FRIDs的成人。
- DeFRID障碍与促进因素通过混合方法(临床医生KAP问卷和定性访谈)、团队会议、留存日志及II期RCT实施数据识别。
主要发现
- DeFRID实施揭示四类挑战:为FRID撤药建立均势的伦理临床困难、招募与留存的操作障碍、跌倒结局判定的方法学复杂性、印度LMIC情境特有约束。
- 印度LMIC情境约束包括减停指南有限、多重用药正常化、照护协调碎片化及等级化决策。
- 全球RCT显示低临床医生依从性、短随访期、排除衰弱或认知受损老人的限制性入选标准及资源密集干预限制可扩展性。
临床怎么用
- 临床应识别并减停FRIDs以减少多重用药和跌倒,但需应对伦理、操作与方法学挑战。
- 实施减停时应整合培训、共享决策、情境化指南和利益相关者参与等多层次策略。
局限性
- 为叙述性综述,非系统评价,证据综合可能受选择偏倚影响。
- DeFRID为正在进行的RCT,其过程评估数据可能不完整。
- 全球RCT证据存在低依从性、短随访及限制性入选等局限,影响外推。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Deprescribing fall risk-increasing drugs (FRIDs) is essential for reducing polypharmacy and falls in older adults, yet randomized controlled trials (RCTs) face unique implementation challenges. The DeFRID study is an ongoing multi-center RCT evaluating an ARMOR-based deprescribing intervention versus usual care in adults aged ≥60 years prescribed FRIDs. The objectives of this review are threefold: (1) to describe practical challenges encountered during a multi-center deprescribing RCT in India; (2) to propose a conceptual framework for categorizing these barriers; and (3) to contextualize DeFRID's experience within the broader deprescribing research landscape. METHODS: We conducted a narrative review with systematic scoping elements, synthesizing global RCT evidence from PubMed, OpenAlex, and Google Scholar (inception-December 2025) with DeFRID process evaluation data. DeFRID barriers and facilitators were identified via mixed-methods (clinician KAP questionnaire and qualitative interviews), team meetings, retention logs, and Phase II RCT implementation data, thematically categorized, then compared with global RCT challenges. RESULTS: DeFRID implementation revealed four challenge categories: ethical-clinical difficulties establishing equipoise for FRID withdrawal; operational barriers to recruitment and retention; methodological complexities in fall outcome ascertainment; and context-specific constraints unique to the Indian LMIC setting-limited deprescribing guidelines, polypharmacy normalization, fragmented care coordination, and hierarchical decision-making. Global RCTs revealed substantial implementation challenges: low clinician adherence, short follow-up periods, restrictive eligibility excluding frail or cognitively impaired older adults, and resource-intensive interventions limiting scalability. CONCLUSIONS: Deprescribing FRIDs in older adults is impeded by ethical, operational, methodological, and provider-patient challenges, necessitating multilevel strategies integrating training, shared decision-making, context-specific guidelines, and stakeholder engagement for scalable implementation.
引用
- Eerike M, Varatharajan S, Rajendran P, et al. Deprescribing Fall Risk-Increasing Drugs in Older Adults: Implementation Challenges and a Conceptual Framework from the DeFRID Trial and Global Evidence. J Gerontol A Biol Sci Med Sci. 2026. PMID: 42848531. doi:10.1093/gerona/glag248
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。